National Research Council (U.S.). Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II, & ebrary, Inc. (2011). Risk-characterization framework for decision-making at the food and drug administration. National Academies Press.
توثيق أسلوب شيكاغو (الطبعة السابعة عشر)National Research Council (U.S.). Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II, و Inc ebrary. Risk-characterization Framework for Decision-making at the Food and Drug Administration. Washington, DC: National Academies Press, 2011.
توثيق جمعية اللغة المعاصرة MLA (الإصدار التاسع)National Research Council (U.S.). Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II, و Inc ebrary. Risk-characterization Framework for Decision-making at the Food and Drug Administration. National Academies Press, 2011.